These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36760590)

  • 21. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
    Moon JH; Kim W; Koo BK; Cho NH;
    Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment.
    Yu Q; He R; Jiang H; Wu J; Xi Z; He K; Liu Y; Zhou T; Feng M; Wan P; Yan H; Xia Q
    J Clin Transl Hepatol; 2022 Dec; 10(6):1034-1041. PubMed ID: 36381086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population.
    Fan J; Luo S; Ye Y; Ju J; Zhang Z; Liu L; Yang J; Xia M
    Nutr Metab (Lond); 2021 Sep; 18(1):82. PubMed ID: 34496912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States.
    Xie ZQ; Li HX; Tan WL; Yang L; Ma XW; Li WX; Wang QB; Shang CZ; Chen YJ
    Front Nutr; 2021; 8():795391. PubMed ID: 35187020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between metabolic dysfunction-associated fatty liver disease and low muscle mass in an asymptomatic Korean population.
    Seo JY; Cho EJ; Kim MJ; Kwak MS; Yang JI; Chung SJ; Yim JY; Yoon JW; Chung GE
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2953-2960. PubMed ID: 36222309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthy Eating Index-2015 in relation to risk of metabolic dysfunction-associated fatty liver disease among US population: National Health and Nutrition Examination Survey 2017-2018.
    Zhang W; Wang X; Huang J; Wang S; Yao Q; Li H
    Front Nutr; 2022; 9():1043901. PubMed ID: 36712521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
    Kang SH; Cho Y; Jeong SW; Kim SU; Lee JW;
    Clin Mol Hepatol; 2021 Apr; 27(2):257-269. PubMed ID: 33751877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment.
    Shao C; Ye J; Li X; Lin Y; Feng S; Liao B; Wang W; Gong X; Zhong B
    J Clin Transl Hepatol; 2022 Dec; 10(6):1013-1026. PubMed ID: 36381107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
    Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
    Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting serum fructose is associated with metabolic dysfunction-associated fatty liver disease: A prospective study.
    Fan Y; Zhang Y; Chen C; Ying Z; Su Q; Li X; Chen Y
    Hepatol Res; 2023 Jun; 53(6):479-488. PubMed ID: 36745152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the Disease.
    Wong VW; Wong GL; Woo J; Abrigo JM; Chan CK; Shu SS; Leung JK; Chim AM; Kong AP; Lui GC; Chan HL; Chu WC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2161-2171.e5. PubMed ID: 33137486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease.
    Wu X; Cheung CKY; Ye D; Chakrabarti S; Mahajan H; Yan S; Song E; Yang W; Lee CH; Lam KSL; Wang C; Xu A
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3230-e3240. PubMed ID: 35532410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adipokine (adiponectin-rs1501299) Gene Variant and Patient Characteristics in Relation to Metabolic-associated Fatty Liver Disease.
    Mohamed AA; Hassanin S; Mohamed AA; Zaafar D; Mohamed R; Hassan MB; Hassanin AA; Alsayed Abouahmad E; Sakr MA; Abd El Salam SM; Abdelghafour RAM; Muharram NM; Darwish MK; Faried S; Nasraldin K; Hafez W
    J Clin Exp Hepatol; 2024; 14(5):101409. PubMed ID: 38699515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
    Liu S; Wang J; Wu S; Niu J; Zheng R; Bie L; Xin Z; Wang S; Lin H; Zhao Z; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Bi Y; Li M; Xu Y
    Metabolism; 2021 Jul; 120():154779. PubMed ID: 33895182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease.
    Huh JH; Kim KJ; Kim SU; Cha BS; Lee BW
    Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):241-247. PubMed ID: 35365418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of metabolic-associated fatty liver disease (MAFLD) in adults: a population-based study in Northeastern Iran.
    Taheri E; Moslem A; Mousavi-Jarrahi A; Hatami B; Pourhoseingholi MA; Asadzadeh Aghdaei H; Zali MR
    Gastroenterol Hepatol Bed Bench; 2021; 14(Suppl1):S102-S111. PubMed ID: 35154609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Hepatic Dendritic Cells in Liver Biopsies Showing Steatosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Associated with Obesity.
    Barranco-Fragoso B; Pal SC; Díaz-Orozco LE; Dorantes-Heredia R; Qi X; Méndez-Sánchez N
    Med Sci Monit; 2022 Aug; 28():e937528. PubMed ID: 35934868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of metabolic dysfunction-associated fatty liver disease on liver cancer risk in a population with chronic hepatitis B virus infection: A nationwide study.
    Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
    Hepatol Res; 2022 Dec; 52(12):975-984. PubMed ID: 35976670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotemporal substitution of different behaviour patterns with the presence of MAFLD in Chinese adults.
    Wang J; Qi Y; Xin Z; Huo Y; Wan Q; Qin Y; Hu R; Shi L; Su Q; Yu X; Yan L; Qin G; Tang X; Chen G; Xu M; Xu Y; Wang T; Zhao Z; Gao Z; Wang G; Shen F; Luo Z; Chen L; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Yang T; Deng H; Chen L; Zeng T; Zhao J; Mu Y; Wu S; Chen Y; Lu J; Wang W; Ning G; Bi Y; Li M;
    Liver Int; 2022 Dec; 42(12):2683-2695. PubMed ID: 36166316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease.
    Sohn W; Kwon HJ; Chang Y; Ryu S; Cho YK
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e1135-e1148. PubMed ID: 34224877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.